Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tina Weigel

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Acta Crystallographica. Section E, Crystallographic Communications|March 8, 2024
'Young crystallographers' rejuvenate crystallography in GermanyFlorian Meurer, Jakob Möbs, Melanie Nentwich, et al.
International Journal of Women'S Health|April 8, 2015
Vulvar cancer: epidemiology, clinical presentation, and management optionsIbrahim Alkatout, Melanie Schubert, Nele Garbrecht, et al.
Journal of Applied Crystallography|July 21, 2020
X-ray diffraction using focused-ion-beam-prepared single crystalsTina Weigel, Claudia Funke, Matthias Zschornak, et al.
Journal of Synchrotron Radiation|December 14, 2023
Treatment of multiple-beam X-ray diffraction in energy-dependent measurementsMelanie Nentwich, Matthias Zschornak, Tina Weigel, et al.
Journal of Synchrotron Radiation|January 5, 2021
Sample chamber for synchrotron based in-situ X-ray diffraction experiments under electric fields and temperatures between 100 K and 1250 KMelanie Nentwich, Tina Weigel, Carsten Richter, et al.
Translational Oncology|August 25, 2009
Combination of enzastaurin and pemetrexed inhibits cell growth and induces apoptosis of chemoresistant ovarian cancer cells regulating extracellular signal-regulated kinase 1/2 phosphorylationKaren Bräutigam, Dirk Olaf Bauerschlag, Marion Tina Weigel, et al.
Journal of Cancer Research and Clinical Oncology|May 10, 2008
Novel treatment of ovarian cancer cell lines with Imatinib mesylate combined with Paclitaxel and Carboplatin leads to receptor-mediated antiproliferative effectsChristoph Mundhenke, Marion Tina Weigel, Klarissa Hanja Sturner, et al.
Anticancer Research|July 2, 2014
Significance of syndecan-1 expression in ductal carcinoma in situ of the breastKatharina Tiemann, Marion Tina Weigel, Ibrahim Alkatout, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Acta Crystallographica. Section E, Crystallographic Communications|March 8, 2024
'Young crystallographers' rejuvenate crystallography in GermanyFlorian Meurer, Jakob Möbs, Melanie Nentwich, et al.
International Journal of Women'S Health|April 8, 2015
Vulvar cancer: epidemiology, clinical presentation, and management optionsIbrahim Alkatout, Melanie Schubert, Nele Garbrecht, et al.
Journal of Applied Crystallography|July 21, 2020
X-ray diffraction using focused-ion-beam-prepared single crystalsTina Weigel, Claudia Funke, Matthias Zschornak, et al.
Journal of Synchrotron Radiation|December 14, 2023
Treatment of multiple-beam X-ray diffraction in energy-dependent measurementsMelanie Nentwich, Matthias Zschornak, Tina Weigel, et al.
Journal of Synchrotron Radiation|January 5, 2021
Sample chamber for synchrotron based in-situ X-ray diffraction experiments under electric fields and temperatures between 100 K and 1250 KMelanie Nentwich, Tina Weigel, Carsten Richter, et al.
Translational Oncology|August 25, 2009
Combination of enzastaurin and pemetrexed inhibits cell growth and induces apoptosis of chemoresistant ovarian cancer cells regulating extracellular signal-regulated kinase 1/2 phosphorylationKaren Bräutigam, Dirk Olaf Bauerschlag, Marion Tina Weigel, et al.
Journal of Cancer Research and Clinical Oncology|May 10, 2008
Novel treatment of ovarian cancer cell lines with Imatinib mesylate combined with Paclitaxel and Carboplatin leads to receptor-mediated antiproliferative effectsChristoph Mundhenke, Marion Tina Weigel, Klarissa Hanja Sturner, et al.
Anticancer Research|July 2, 2014
Significance of syndecan-1 expression in ductal carcinoma in situ of the breastKatharina Tiemann, Marion Tina Weigel, Ibrahim Alkatout, et al.
Pageof 1